The impact of infectious diseases upon neuroendocrine circuits

NeuroImmunoModulation

Volumn 16, Issue 2, 2009, Pages 96-105

  Pérez, Ana Rosa ^a   Bottasso, Oscar ^a   Savino, Wilson ^b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cytokines; Extracellular matrix; Glucocorticoids; Hypothalamus pituitary adrenal axis; Intracellular pathogen infections; Sex hormones; Thymic atrophy; Thymus

Indexed keywords

CYTOKINE;

ADRENAL GLAND; ENDOCRINE DISEASE; EXTRACELLULAR MATRIX; HORMONE RELEASE; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; INFECTION; INFLAMMATION; MICROENVIRONMENT; MICROORGANISM; NEUROENDOCRINE SYSTEM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; CATTLE; COMMUNICABLE DISEASES; CYTOKINES; DEHYDROEPIANDROSTERONE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLUCOCORTICOIDS; HORMONES; HOST-PARASITE INTERACTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; MALE; MICE; MODELS, IMMUNOLOGICAL; PAPIO; PARASITIC DISEASES, ANIMAL; PITUITARY-ADRENAL SYSTEM; STRESS, PHYSIOLOGICAL; TH1 CELLS; TH2 CELLS;

EID: 60149097829     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000180264     Document Type: Review

References (97)

1. Ader R, Cohen N: Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 1995;349:99-103.
2. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES: The sympathetic nerve - An integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595-638.
3. Sterling P, Eyer J: Allostasis: a new paradigm to explain arousal pathology; in Fisher S, Reason J (eds): Handbook of Life Stress, Cognition and Health. New York, Wiley, 1988, pp 629-649.
4. Kronfol Z, Remick DG: Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000;157:683-694.
5. Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A, Besedovsky HO: A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci USA 1998;95:7778-7783.
6. Turnbull AV, Rivier CL: Regulation of the hypothalamic pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 1999;79:1-71.
7. Besedovsky H, del Rey A, Sorkin E, Da Prada M, Burri R, Honegger C: The immune response evokes changes in brain noradrenergic neurons. Science 1983;221:564-566.
8. Besedovsky H, del Rey A, Sorkin E, Dinarello CA: Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986;233:652-654.
9. Hart BL: Biological basis of the behaviour of sick animals. Neurosci Biobehav Rev 1988;12:123-137.
10. Reul JM, de Kloet ER: Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985;117:2505-2511.
11. De Kloet ER: Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 1991;12:95-164.
12. Pitzalis C, Pipitone N, Perretti M: Regulation of leukocyte-endothelial interactions by glucocorticoids. Ann N Y Acad Sci 2002;966:108-118.
13. Sapolsky R, Michaelromero L, Munck A: How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000;21:55-89.
14. Brinkmann V, Kristofic C: Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD41 effector T cells generated from CD45RO- and CD45RO+ subsets. J Immunol 1995;155:3322-3328.
15. Ramírez F, Fowell DJ, Puclavec M, Simmonds S, Mason D: Glucocorticoids promote a Th2 cytokine response by CD41 T cells in vitro. J Immunol 1996;156:2406-2410.
16. Morrow LE, McClellan JL, Conn CA, Kluger MJ: Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide. Am J Physiol 1993;264:1010-1016.
17. Nakano K, Suzuki S, Oh C: Significance of increased secretion of glucocorticoids in mice and rats injected with bacterial endotoxin. Brain Behav Immun 1987;1:159-172.
18. Coelho M, Souza G, Pela I: Endotoxin-induced fever is modulated by endogenous glucocorticoids in rats. Am J Physiol 1992;263:423-427.
19. Bertini R, Bianchi M, Ghezzi P: Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumour necrosis factor. J Exp Med 1988;167:1708-1712.
20. Sternberg E, Hill J, Chrousos G, Kamilaris T, Listwak S, Gold P, Wilder R: Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA 1989;86:2374-2378.
21. Sternberg E, Young W, Bernardini R, Calogero A, Chrousos G, Gold P, Wilder R: A central nervous system defect in bio-synthesis of CRH is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 1989;86:4771-4775.
22. Peretti M, Becherucci C, Scapigliati G, Parente L: The effect of adrenalectomy on interleukin-1 release in vitro and in vivo. Br J Pharmacol 1989;98:1137-1142.
23. Harbuz S, Lightman S: Stress and the hypothalamo-pituitary-adrenal axis: acute chronic and immunological activation. J Endocrinol 1992;134:327-339.
24. Barber AE, Coyle SM, Marano MA, Fischer E, Calvano SE, Fong Y, Moldawer LL, Lowry SF: Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 1993;150:1999-2006.
25. Wiegers GJ, Reul JM, Holsboer F, De Kloet ER: Enhancement of rat splenic lymphocyte mitogenesis after short term pre-exposure to corticosteroids in vitro. Endocrinology 1994;135:2351-2357.
26. Wiegers GJ, Labeur MS, Stec IE, Klinkert WE, Holsboer F, Reul JM: Glucocorticoids accelerate anti-T cell receptor-induced T cell growth. J Immunol 1995;155:1893-1902.
27. Wiegers GJ, Reul JM: Induction of cytokine receptors by glucocorticoids: functional and pathological significance. Trends Pharmacol Sci 1998;19:317-321.
28. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-1362.
29. Lowry SF: Cytokine mediators of immunity and inflammation. Arch Surg 1993;128:1235-1241.
30. Besedovsky HO, del Rey A: Immuno-neuroendocrine interactions: facts and hypotheses. Endocr Rev 1996;17:64-102.
31. Besedovsky H, del Rey A, Klusman I, Furukawa H, Arditi G, Kabiersch A: Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J Steroid Biochem Mol Biol 1991;40:613-618.
32. Iseki R, Mukai M, Iwata M: Regulation of T lymphocyte apoptosis. Signals for the antagonism between activation and glucocorticoid induced death. J Immunol 1991;47:4286-4292.
33. Iwata M, Hanaoka S, Sato K: Rescue of thymocytes and T cell hybridomas from glucocorticoid induced apoptosis by stimulation via the T cell receptor/CD3 complex: a possible in vitro model for positive selection of the T cell repertoire. Eur J Immunol 1991;21:643-648.
34. McEwen BS: Protective and damaging effects of stress mediators. N Engl J Med 1998;338:171-179.
35. Libonati RM, de Mendonca BB, Maues JA, Quaresma JA, de Souza JM: Some aspects of the behavior of the hypothalamus-pituitary-adrenal axis in patients with uncomplicated Plasmodium falciparum malaria: cortisol and dehydroepiandrosterone levels. Acta Trop 2006;98:270-276.
36. Reincke M, Heppner C, Petzke F, Allolio B, Arlt W, Mbulamberi D, Siekmann L, Vollmer D, Winkelmann W, Chrousos GP: Impairment of adrenocortical function associated with increased plasma tumor necrosis factor-alpha and interleukin-6 concentrations in African trypanosomiasis. Neuroimmunomodulation 1994;1:14-22.
37. Correa-de-Santana E, Paez-Pereda M, Theodoropoulou M, Kenji Nihei O, Gruebler Y, Bozza M, Arzt E, Villa-Verde DM, Renner U, Stalla J, Stalla GK, Savino W: Hypothalamus-pituitary-adrenal axis during Trypanosoma cruzi acute infection in mice. J Neuroimmunol 2006;173:12-22.
38. Roggero E, Perez AR, Tamae-Kakazu M, Piazzon I, Nepomnaschy I, Besedovsky HO, Bottasso OA, del Rey A: Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. J Endocrinol 2006;190:495-503.
39. Evans CA, Harbuz MS, Ostenfeld T, Norrish A, Blackwell JM: Nramp1 is expressed in neurons and is associated with behavioural and immune responses to stress. Neurogenetics 2001;3:69-78.
40. Ruiz MR, Quinones AG, Diaz NL, Tapia FJ: Acute immobilization stress induces clinical and neuroimmunological alterations in experimental murine cutaneous leishmaniasis. Br J Dermatol 2003;149:731-718.
41. Morales-Montor J, Newhouse E, Mohamed F, Baghdadi A, Damian RT: Altered levels of hypothalamic-pituitary-adrenocortical axis hormones in baboons and mice during the course of infection with Schistosoma mansoni. J Infect Dis 2001;183:313-320.
42. Leal AM, Magalhaes PK, Souza CS, Foss NT: Adrenocortical hormones and interleukin patterns in leprosy. Parasite Immunol 2003;25:457-461.
43. del Rey A, Mahuad CV, Bozza V, Bogue C, Farroni MA, Bay ML, Bottasso OA, Besedovsky HO: Endocrine and cytokine responses in humans with pulmonary tuberculosis. Brain Behav Immun 2007;21:171-179.
44. Silverman MN, Pearce BD, Biron CA, Miller AH: Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol 2005;18:41-78.
45. Millar AB, Foley NM, Singer M, Johnson NM, Meager A, Rook GA: Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 1989;ii:712-714.
46. Golden JM, Tarleton RL: Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity. Exp Parasitol 1991;72:391-402.
47. Sugawara I, Yamada H, Hua S, Mizuno S: Role of interleukin-1 type 1 receptor in mycobacterial infection. Microbiol Immunol 2001;45:743-750.
48. Roggero E, Perez A, Tamae-Kakazu M, Piazzon I, Nepomnaschy I, Wietzerbin J, Serra E, Revelli S, Bottasso O: Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities. Clin Exp Immunol 2002;128:421-428.
49. Leite de Moraes MC, Hontebeyrie-Joskowicz M, Leboulenger F, Savino W, Dardenne M, Lepault F: Studies on the thymus in Chagas' disease. 2. Thymocyte subset fluctuations in Trypanosoma cruzi-infected mice: relationship to stress. Scand J Immunol 1991;33:267-275.
50. Perez AR, Roggero E, Nicora A, Palazzi J, Besedovsky HO, Del Rey A, Bottasso OA: Thymus atrophy during Trypanosoma cruzi infection is caused by an immuno-endocrine imbalance. Brain Behav Immun 2007;21:890-900.
51. Davis TM, Li TA, Tran QB, Robertson K, Dyer JR, Phan TD, Meyer D, Beaman MH, Trinh KA: The hypothalamic-pituitary-adrenocortical axis in severe falciparum malaria: effects of cytokines. J Clin Endocrinol Metab 1997;82:3029-3033.
52. Abebe G, Eley RM, Ole-MoiYoi OK: Reduced responsiveness of the hypothalamic-pituitary-adrenal axis in Boran (Bos inducus) cattle infected with Trypanosoma congolense. Acta Endocrinol (Copenh) 1993;129:75-80.
53. Ben-Hur T, Conforti N, Itzik A, Weidenfeld J: Effects of HSV-1, a neurotropic virus, on the hypothalamic-pituitary-adrenocortical axis in rats. Brain Res 1995;702:17-22.
54. Silverman MN, Miller AH, Biron CA, Pearce BD: Characterization of an interleukin-6- and adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection. Endocrinology 2004;145:3580-3589.
55. Chittiprol S, Kumar AM, Satishchandra P, Taranath Shetty K, Bhimasena Rao RS, Subbakrishna DK, Philip M, Satish KS, Ravi Kumar H, Kumar M: Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India. Psychoneuroendocrinology 2008;33:30-40.
56. Yen SS: Relationship with the severity of pulmonary involvement. Dehydroepiandrosterone sulfate and longevity: new clues for an old friend. Proc Natl Acad Sci USA 2001;98:8167-8169.
57. Bozza VV, D'Attilio L, Mahuad CV, Giri AA, del Rey A, Besedovsky H, Bottasso O, Bay ML: Altered cortisol/DHEA ratio in tuberculosis patients and its relationship with abnormalities in the mycobacterial-driven cytokine production by peripheral blood mononuclear cells. Scand J Immunol 2007;66:97-103.
58. Keven K, Uysal AR, Erdogan G: Adrenal function during tuberculous infection and effects of antituberculosis treatment on endogenous and exogenous steroids. Int J Tuberc Lung Dis 1998;2:419-424.
59. Ellis ME, Tayoub F: Adrenal function in tuberculosis. Br J Dis Chest 1986;80:7-12.
60. Rook G, Honour J, Kon O, Wilkinson R, Davidson R, Shaw R: Urinary adrenal steroid metabolites in tuberculosis: a new clue to pathogenesis. Q J Med 1996;89:333-341.
61. Rook GA, Hernandez-Pando R: Pathogenetic role, in human and murine tuberculosis, of changes in the peripheral metabolism of glucocorticoids and antiglucocorticoids. Psychoneuroendocrinology 1997;22:109-113.
62. Chen CC, Parker CR Jr: Adrenal androgens and the immune system. Semin Reprod Med 2004;22:369-377.
63. Abebe F, Birkeland KI, Gaarder PI, Petros B, Gundersen SG: The relationships between dehydroepiandrosterone sulphate (DHEAS), the intensity of Schistosoma mansoni infection and parasite-specific antibody responses. A cross-sectional study in residents of endemic communities in north-east Ethiopia. APMIS 2003;111:319-328.
64. Fulford AJ, Webster M, Ouma JH, Kimani G, Dunne DW: Puberty and age-related changes in susceptibility to schistosome infection. Parasitol Today 1998;14:23-26.
65. Santos CD, Toldo MP, Santello FH, Filipin MD, Brazão V, do Prado Júnior JC: Dehydroepiandrosterone increases resistance to experimental infection by Trypanosoma cruzi. Vet Parasitol 2008;153:238-243.
66. Santos CD, Toldo MP, Levy AM, Kawasse LM, Zucoloto S, do Prado JC Jr: Dehydroepiandrosterone affects Trypanosoma cruzi tissue parasite burdens in rats. Acta Trop 2007;102:143-150.
67. Wilder R: Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 1995;13:307-338.
68. Oktenli C, Doganci L, Ozgurtas T, Araz RE, Tanyuksel M, Musabak U, Sanisoglu SY, Yesilova Z, Erbil MK, Inal A: Transient hypogonadotrophic hypogonadism in males with acute toxoplasmosis: suppressive effect of interleukin-1 beta on the secretion of GnRH. Hum Reprod 2004;19:859-866.
69. Setian N, Andrade RS, Kuperman H, Manna TD, Dichtchekenian V, Damiani D: Precocious puberty: an endocrine manifestation in congenital toxoplasmosis. J Pediatr Endocrinol Metab 2002;15:1487-1490.
70. Massa G, Vanderschueren-Lodeweyckx M, Van Vliet G, Craen M, de Zegher F, Eggermont E: Hypothalamo-pituitary dysfunction in congenital toxoplasmosis. Eur J Pediatr 1989;148:742-744.
71. Reincke M, Arlt W, Heppner C, Petzke F, Chrousos GP, Allolio B: Neuroendocrine dysfunction in African trypanosomiasis. The role of cytokines. Ann NY Acad Sci 1998;840:809-821.
72. Reincke M, Allolio B, Petzke F, Heppner C, Mbulamberi D, Vollmer D, Winkelmann W, Chrousos GP: Thyroid dysfunction in African trypanosomiasis: a possible role for inflammatory cytokines. Clin Endocrinol (Oxf) 1993;39:455-461.
73. Petzke F, Heppner C, Mbulamberi D, Winkelmann W, Chrousos GP, Allolio B, Reincke M: Hypogonadism in Rhodesian sleeping sickness: evidence for acute and chronic dysfunction of the hypothalamic-pituitary-gonadal axis. Fertil Steril 1996;65:68-75.
74. Wilder RL: Hormones and autoimmunity: animal models of arthritis. Baillieres Clin Rheumatol 1996;10:259-271.
75. Correa-de-Santana E, Pinto-Mariz F, Savino W: Immunoneuroendocrine interactions in Chagas disease. Ann NY Acad Sci 2006;1088:274-283.
76. Teixeira AR, Nascimento RJ, Sturm NR: Evolution and pathology in Chagas disease: a review. Mem Inst Oswaldo Cruz 2006;101:463-491.
77. Calvet CM, Meuser M, Almeida D, Meirelles MN, Pereira MC: Trypanosoma cruzi-cardiomyocyte interaction: role of fibronectin in the recognition process and extracellular matrix expression in vitro and in vivo. Exp Parasitol 2004;107:20-30.
78. Moody TN, Ochieng J, Villalta F: Novel mechanism that Trypanosoma cruzi uses to adhere to the extracellular matrix mediated by human galectin-3. FEBS Lett 2000;470:305-308.
79. Silva AA, Roffe E, Lannes-Vieira J: Expression of extracellular matrix components and their receptors in the central nervous system during experimental Toxoplasma gondii and Trypanosoma cruzi infection. Braz J Med Biol Res 1999;32:593-600.
80. Murray M: The pathology of African trypanosomiasis; in Brent L, Holborow J (eds): Progress of Immunology II. Amsterdam, North-Holland Publishing Co., 1974, vol 4: Clinical Aspects, pp 182-192.
81. Khuth ST, Akaoka H, Pagenstecher A, Verlaeten O, Belin MF, Giraudon P, Bernard A: Morbillivirus infection of the mouse central nervous system induces region-specific up-regulation of MMPs and TIMPs correlated to inflammatory cytokine expression. J Virol 2001;75:8268-8282.
82. Girones N, Fresno M: Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? Trends Parasitol 2003;19:19-22.
83. Kierszenbaum F: Chagas' disease and the autoimmunity hypothesis. Clin Microbiol Rev 1999;12:210-223.
84. Feldman S, García G, Svetaz MJ, Avila JL, Revelli S, Bottasso OA, Marcipar A: Evidence that antisulphatide autoantibodies from experimentally Trypanosoma cruzi-infected rats bind to homologous neural tissue. Parasitol Res 1999;85:446-451.
85. Teixeira Vde P, Hial V, Gomes RA, Castro EC, Reis M das G, Rodrigues ML, Guimaraes JV, Dos Reis MA: Correlation between adrenal central vein parasitism and heart fibrosis in chronic chagasic myocarditis. Am J Trop Med Hyg 1997;56:177-180.
86. Escobedo G, Roberts CW, Carrero JC, Morales-Montor J: Parasite regulation by host hormones: an old mechanism of host exploitation? Trends Parasitol 2005;21:588-593.
87. Maswoswe SM, Peters W, Warhurst DC: Corticosteroid stimulation of the growth of Plasmodium falciparum gametocytes in vitro. Ann Trop Med Parasitol 1985;79:607-616.
88. Freilich D, Ferris S, Wallace M, Leach L, Kallen A, Frincke J, Ahlem C, Hacker M, Nelson D, Hebert J: 16alpha-bromoepiandrosterone, a dehydroepiandrosterone (DHEA) analogue, inhibits Plasmodium falciparum and Plasmodium berghei growth. Am J Trop Med Hyg 2000;63:280-283.
89. Ghansah TJ, Ager EC, Freeman-Junior P, Villalta F, Lima MF: Epidermal growth factor binds to a receptor on Trypanosoma cruzi amastigotes inducing signal transduction events and cell proliferation. J Eukaryot Microbiol 2002;49:383-390.
90. Charlab R, Blaineau C, Schechtman D, Barcinski MA: Granulocyte-macrophage colony-stimulating factor is a growth-factor for promastigotes of Leishmania mexicana amazonensis. J Protozool 2003;37:352-357.
91. Baumann H, Gauldie J: The acute phase response. Immunol Today 1994;15:74-80.
92. Hart BL: Behavioral adaptations to pathogens and parasites: five strategies. Neurosci Biobehav Rev 1990;14:273-294.
93. Savino W, Arzt E, Dardenne M: Immunoneuroendocrine connectivity: the paradigm of the thymus-hypothalamus/pituitary axis. Neuroimmunomodulation 1999;6:126-136.
94. Jondal M, Pazirandeh A, Okret S: Different roles for glucocorticoids in thymocyte homeostasis? Trends Immunol 2004;25:595-600.
95. Smaniotto S, Mello-Coelho V, Villa-Verde DM, Pléau JM, Postel-Vinay MC, Dardenne M, Savino W: Growth hormone modulates thymocyte development in vivo through a combined action of laminin and CXCL12. Endocrinology 2005;146:3005-3017.
96. Rivera MT, Marques De Araujo S, Ralf Lucas R, Deman J, Truyens C, Defresne MP, et al: High tumor necrosis factor alpha (TNF-α) production in Trypanosoma cruzi-infected pregnant mice and increased TNF-α gene transcription in their offspring. Infect Immun 1995;63:591-595.
97. Savino W, Villa-Verde DM, Mendes-da-Cruz DA, Silva-Monteiro E, Pérez AR, María del Aoki MP, Bottasso O, Guiñazú N, Silva-Barbosa SD, Gea S: Cytokines, growth factors and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi. Cytokine Growth Factor Rev 2007;18:107-124.